Rv1385 Orotidine 5'-phosphate decarboxylase (EC

Symbol Product Feature Type Start End Strand Length AA Length is TF
Rv1385 pyrF Orotidine 5'-phosphate decarboxylase (EC CDS 1560445 1561269 + 825 274 FALSE

Rv1385 (Orotidine 5'-phosphate decarboxylase (EC is predicted to be co-regulated in modules bicluster_0104 with residual 0.59 and bicluster_0137 with residual 0.49.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 3,600.00 and 3,500.00 for bicluster_0104 and 850.00 and 1,200.00 for bicluster_0137 respectively.

These modules are enriched for following go terms: pyrimidine nucleobase biosynthetic proce..., pyrimidine nucleobase metabolic process, nucleobase biosynthetic process 'de novo' pyrimidine nucleobase biosynth..., pyrimidine-containing compound biosynthe..., pyrimidine-containing compound metabolic..., organonitrogen compound metabolic proces..., nucleobase-containing small molecule met..., carbon-nitrogen ligase activity, with gl....

This gene is found to be for growth on cholesterol.

Mutant available?:

Product (LegacyBRC) Product (RefSeq)
Orotidine 5&apos-phosphate decarboxylase orotidine 5'-phosphate decarboxylase
Operon # Operon
928 - - - - - -
PATRIC Locus Tag Enzyme Name PATRIC Pathways Transcriptomics


Orotidine-5'-phosphate decarboxylase Pyrimidine metabolism
Locus Tuberculist Genome View


Locus Tag KEGG Pathways


Pyrimidine metabolism

Total items in this category:  


Metabolic pathways

Total items in this category:  
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network


GI Number Protein ID Blast Conserved Domains
15608524 NP_215901.1 Run

orotidine-5'-phosphate decarboxylase activity

orotidine-5'-phosphate decarboxylase activity

Catalysis of the reaction: H(+) + orotidine 5'-phosphate = CO(2) + UMP.
GO Category: 
Total items in this category:  
No TFOE experiment results were found
Quantitative Proteomics Data
t-test p-value Cholesterol/Glycerol Ratio

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: